Clinical pathogenetic characteristics of porphyria cutanea tarda course in residents of the Krasnodar Territory


Cite item

Full Text

Abstract

Porphyria cutanea tarda (PCT) is a multifactorial photodermatosis with the clinical manifestations which depend on the season, insolation level, and occupational factors. Case history, clinical symptom complexes, and the total scope of laboratory data (serum iron and transaminases, urinary uroporphyrin, and fecal coproporphyrin) are analyzed for each patient with PCT, resident of the Krasnodar Territory, over the period of 2011-2013. Relationships between the relapse development, course and clinical manifestations of PCT and the season, individual features, and concomitant diseases are detected. Biochemical findings indicate high levels of serum transaminases and iron, uroporphyrins, and coproporphyrins. Improvement of the complex of diagnostic, therapeutic and preventive measures, standardization of follow-up of the patients, and cooperation of dermatovenereologists and specialists in allied fields can limit the prevalence of PCT and lead to a stable remission of the disease.

About the authors

Taisiya G. Kuznetsova

Kuban State Medical University

Email: taya1504@mail.ru
MD, PhD 350000, Krasnodar, Russia

M. M Tlish

Kuban State Medical University

Email: tlish_mm@mail.ru
Кафедра дерматовенерологии; доктор мед. наук, профессор 350000, Krasnodar, Russia

N. L Sycheva

Kuban State Medical University

Email: nfaustova@mail.ru
Кафедра дерматовенерологии; кандидат мед. наук, ассистент 350000, Krasnodar, Russia

Zh. Yu Naatyzh

Kuban State Medical University

Email: nzhannau@mail.ru
Кафедра дерматовенерологии; кандидат мед. наук, ассистент 350000, Krasnodar, Russia

References

  1. Комарова Л.А., Кирьянова В.В. Применение ультрафиолетового излучения в физиотерапии и косметологии. СПб.: СПб. МАПО; 2006.
  2. Wickliffe J.K., Abdel-Rahman S.Z., Lee C., Kormos-Hallberg C., Sood G., Rondelli C.M., et al. CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda. Mol. Med. 2011; 17(3-4): 241-7. doi: 10.2119/molmed.2010.00130.
  3. Balwani M., Desnick R.J. The porphyrias: advances in diagnosis and treatment. Hematol. Am. Soc. Hematol. Educ. Program. 2012; 2012: 19-27.
  4. Чащин А.Ю., Кузнецова Н.П. Роль гепатита С в патогенезе поздней кожной порфирии. Тезисы 2-го Форума медицины и красоты организованный Национальным альянсом дерматологов и косметологов, Москва 24-26 ноября 2009 г. М., 2009.
  5. Тлиш М.М., Кузнецова Т.Г., Сычева Н.Л. Поздняя кожная порфирия: причины запоздалой диагностики дерматоза. Клиническая дерматология и венерология. 2014; 5: 92-7.

Copyright (c) 2015 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies